RETIMIX® is a dietary supplement with an innovative
formulation (Casperiva®) of Curcumin Phospholipid and
Phospholipid Boswellic Acid. Curcumin is a potent anti-
inflammatory while Boswellic acid targets VEGF signaling.
This product is particularly indicated as a therapeutic aid in the
treatment of Diabetic Retinopathy (Diabetic macular Edema),
and acute phase inflammations such as post-surgical edema.
INDICATIONS: WET AGE-RELATED MACULAR
DEGENERATION (AMD), DIABETIC RETINOPATHY,
MACULAR EDEMA, CENTRAL SEROUS
CHORIORETINOPATHY (CSC).
